Transmedics
TMDX
221 hedge funds and large institutions have $1.91B invested in Transmedics in 2023 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 95 increasing their positions, 67 reducing their positions, and 52 closing their positions.
211% more call options, than puts
Call options by funds: $33.9M | Put options by funds: $10.9M
42% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 67
7.14% more ownership
Funds ownership: 99.94% → 107.08% (+7.1%)
8% less funds holding
Funds holding: 240 → 221 (-19)
30% less capital invested
Capital invested by funds: $2.73B → $1.91B (-$817M)
35% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 52
50% less funds holding in top 10
Funds holding in top 10: 10 → 5 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$101M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$61.8M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$44.8M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$41.5M |
| 5 |
Bank of New York Mellon
New York
|
+$26.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$86.1M |
| 2 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$48.4M |
| 3 |
D.E. Shaw & Co
New York
|
-$27M |
| 4 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$19.2M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$15.1M |
TMDX Hedge Fund Activity: Q3 2023 in Review
221 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q3 2023, worth a combined $1.91B — down 30% from $2.73B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of TMDX and 34 opened new positions — a net loss of 18 holders — while 67 trimmed existing stakes and 95 added.
The largest buyer was Fidelity Investments, adding an estimated $101M. The largest seller was Lord, Abbett & Co, cutting an estimated $86.1M.
- 221 institutional investors held Transmedics (TMDX) as of Q3 2023, down from 240 in Q2 2023.
- Funds reported $1.91B of Transmedics stock for Q3 2023, down 30% quarter-over-quarter.
- 34 funds opened new Transmedics positions in Q3 2023 and 52 closed out, a net change of -18 holders.
- The largest Transmedics buyer in Q3 2023 was Fidelity Investments, an estimated $101M added.
- The largest Transmedics seller in Q3 2023 was Lord, Abbett & Co, an estimated $86.1M sold.
Based on aggregated 13F filings for Q3 2023.